Corvus Pharmaceuticals, Inc. (CRVS)

14.35 -0.36 (-2.45%) USD  |  NASDAQ  |  Apr 07, 16:00
14.34 -0.01 (-0.07%) After-Hours: 20:00
More

Corvus Pharmaceuticals Price to Book Value (3y Mean)

Price to Book Value (3y Mean) Chart

View Price to Book Value (3y Mean) for CRVS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value (3y Mean) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Value (3y Mean) Range, Past 5 Years

View Price to Book Value (3y Mean) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value (3y Mean) Benchmarks

View Price to Book Value (3y Mean) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Plus Therapeutics, Inc. --
Geron Corp. Upgrade
Nektar Therapeutics Upgrade
Jaguar Health, Inc. Upgrade